Table of Content


Chapter 1. Global Prenatal & Newborn Genetic Testing Market Executive Summary
1.1. Global Prenatal & Newborn Genetic Testing Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Product Type & Screening
?1.3.2. By Disease & End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Prenatal & Newborn Genetic Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply Side Analysis
??2.3.3.1. Availability
??2.3.3.2. Infrastructure
??2.3.3.3. Regulatory Environment
??2.3.3.4. Market Competition
??2.3.3.5. Economic Viability (Client Perspective)
?2.3.4. Demand Side Analysis
??2.3.4.1. Regulatory Frameworks
??2.3.4.2. Technological Advancements
??2.3.4.3. Ethical & Privacy Considerations
??2.3.4.4. Patient Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Prenatal & Newborn Genetic Testing Market Dynamics
3.1. Market Drivers
?3.1.1. Rising Prevalence of Genetic Disorders
?3.1.2. Expansion of Universal Newborn Screening Programs
?3.1.3. Technological Advances in Next-Generation Sequencing
3.2. Market Challenges
?3.2.1. High Infrastructure and Per-Test Costs
?3.2.2. Stringent Regulatory & Reimbursement Frameworks
?3.2.3. Data Privacy and Ethical Concerns
3.3. Market Opportunities
?3.3.1. Multiplex and Point-of-Care Assay Development
?3.3.2. Emerging Markets with Growing Healthcare Spending
?3.3.3. Integration of AI/ML for Predictive Analytics
Chapter 4. Global Prenatal & Newborn Genetic Testing Market Industry Analysis
4.1. Porter’s Five Forces Model
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
?4.1.6. Futuristic Approach to Porter’s Model
?4.1.7. Impact Analysis
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Prenatal & Newborn Genetic Testing Market Size & Forecasts by Product Type & Screening (2022–2032)
5.1. Segment Dashboard
5.2. By Product Type
?5.2.1. Consumables
?5.2.2. Instruments
5.3. By Screening
?5.3.1. Non-invasive Prenatal Testing
?5.3.2. Chorionic Villus Sampling
?5.3.3. Amniocentesis
?5.3.4. Maternal Serum Screening
Chapter 6. Global Prenatal & Newborn Genetic Testing Market Size & Forecasts by Disease & End User (2022–2032)
6.1. Segment Dashboard
6.2. By Disease
?6.2.1. Down Syndrome
?6.2.2. Phenylketonuria
?6.2.3. Cystic Fibrosis
?6.2.4. Sickle Cell Anemia
6.3. By End User
?6.3.1. Hospitals
?6.3.2. Maternity and Specialty Clinics
?6.3.3. Diagnostic Centers
Chapter 7. Global Prenatal & Newborn Genetic Testing Market Size & Forecasts by Region (2022–2032)
7.1. North America Market
?7.1.1. U.S. Market
??7.1.1.1. By Product & Screening, 2022–2032
??7.1.1.2. By Disease & End User, 2022–2032
?7.1.2. Canada Market
7.2. Europe Market
?7.2.1. UK Market
?7.2.2. Germany Market
?7.2.3. France Market
?7.2.4. Spain Market
?7.2.5. Italy Market
?7.2.6. Rest of Europe Market
7.3. Asia Pacific Market
?7.3.1. China Market
?7.3.2. India Market
?7.3.3. Japan Market
?7.3.4. Australia Market
?7.3.5. South Korea Market
?7.3.6. Rest of Asia Pacific Market
7.4. Latin America Market
?7.4.1. Brazil Market
?7.4.2. Mexico Market
?7.4.3. Rest of Latin America Market
7.5. Middle East & Africa Market
?7.5.1. Saudi Arabia Market
?7.5.2. South Africa Market
?7.5.3. Rest of Middle East & Africa Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
?8.1.1. Illumina, Inc.
?8.1.2. Thermo Fisher Scientific Inc.
?8.1.3. F. Hoffmann-La Roche Ltd.
8.2. Top Market Strategies
8.3. Company Profiles
?8.3.1. Illumina, Inc.
??8.3.1.1. Key Information
??8.3.1.2. Overview
??8.3.1.3. Financial (Subject to Data Availability)
??8.3.1.4. Product Summary
??8.3.1.5. Market Strategies
?8.3.2. Thermo Fisher Scientific Inc.
?8.3.3. F. Hoffmann-La Roche Ltd.
?8.3.4. Agilent Technologies, Inc.
?8.3.5. BGI Genomics Co., Ltd.
?8.3.6. Eurofins Scientific
?8.3.7. Quest Diagnostics Incorporated
?8.3.8. PerkinElmer Inc.
?8.3.9. Natera, Inc.
?8.3.10. Bio-Rad Laboratories, Inc.
?8.3.11. Invitae Corporation
?8.3.12. GeneDx
?8.3.13. Centogene N.V.
?8.3.14. Myriad Genetics, Inc.
?8.3.15. MedGenome Labs Ltd.
Chapter 9. Research Process
9.1. Research Process
?9.1.1. Data Mining
?9.1.2. Analysis
?9.1.3. Market Estimation
?9.1.4. Validation
?9.1.5. Publishing
9.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global market, research methodology
FIG 2. Market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Global market, Porter’s Five Forces model
FIG 7. Global market, PESTEL analysis
FIG 8. Global market, value chain analysis
FIG 9. By Product Type & Screening, 2022 & 2032 (USD Billion)
FIG 10. By Disease & End User, 2022 & 2032 (USD Billion)
FIG 11. Regional snapshot 2022 & 2032 (USD Billion)
FIG 12. North America market 2022 & 2032 (USD Billion)
FIG 13. Europe market 2022 & 2032 (USD Billion)
FIG 14. Asia Pacific market 2022 & 2032 (USD Billion)
FIG 15. Latin America market 2022 & 2032 (USD Billion)
FIG 16. Middle East & Africa market 2022 & 2032 (USD Billion)
FIG 17. Company market share analysis (2023)
? (report contains 50+ figures; list to be updated in final deliverable)

List of Tables

List of Tables
TABLE 1. Global Prenatal & Newborn Genetic Testing market, report scope
TABLE 2. Market estimates & forecasts by Region 2022–2032 (USD Billion)
TABLE 3. Market estimates & forecasts by Product Type & Screening 2022–2032 (USD Billion)
TABLE 4. Market estimates & forecasts by Disease & End User 2022–2032 (USD Billion)
TABLE 5. Market by segment & region, estimates & forecasts 2022–2032 (USD Billion)
TABLE 6. North America market estimates & forecasts 2022–2032 (USD Billion)
TABLE 7. U.S. market estimates & forecasts by segment 2022–2032 (USD Billion)
TABLE 8. Canada market estimates & forecasts by segment 2022–2032 (USD Billion)
TABLE 9. Europe market estimates & forecasts 2022–2032 (USD Billion)
TABLE 10. UK market estimates & forecasts 2022–2032 (USD Billion)
TABLE 11. Asia Pacific market estimates & forecasts 2022–2032 (USD Billion)
TABLE 12. China market estimates & forecasts 2022–2032 (USD Billion)
TABLE 13. Latin America market estimates & forecasts 2022–2032 (USD Billion)
TABLE 14. Middle East & Africa market estimates & forecasts 2022–2032 (USD Billion)
TABLE 15. Key company financials and market shares (2023)
? (report contains 100+ tables; list to be updated in final deliverable)